HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chlamydia ophthalmia neonatorum in Cameroon.

Abstract
In the Ndoungué Hospital in Cameroon 449 new-born babies were examined for a month to check on the occurrence of ophthalmia neonatorum. Silver nitrate eyedrops 1% were applied at birth. The incidence of ophthalmia neonatorum was 19.4%; Chlamydia was found in 8 cases (incidence 1.8%) and gonococci in 4 cases (0.9%). Chemical conjunctivitis was suspected in 13 cases (2.9%). Slight conjunctivitis was seen in 68 cases and severe conjunctivitis in 19 cases (4.2%). A sexually transmitted agent was demonstrated in 6% of the slight cases and in 42% of the severe cases. Ophthalmia neonatorum due to Chlamydia was significantly more frequently severe and without specific features than those due to other agents. Although silver nitrate is still considered to be one of the most effective prophylactic measures for gonococcal ophthalmia neonatorum, in 4 cases this disease still developed. Silver nitrate is ineffective against Chlamydia and is also often the cause of a chemical conjunctivitis. The search is advocated for more efficient medicines in Africa which are effective against both Chlamydia and resistant gonoccoci.
AuthorsN J Buisman, T Abong Mwemba, G Garrigue, J P Durand, J S Stilma, T M van Balen
JournalDocumenta ophthalmologica. Advances in ophthalmology (Doc Ophthalmol) 1988 Oct-Nov Vol. 70 Issue 2-3 Pg. 257-64 ISSN: 0012-4486 [Print] Netherlands
PMID3266135 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Silver Nitrate
Topics
  • Cameroon
  • Chlamydia Infections (drug therapy, epidemiology)
  • Chlamydia trachomatis
  • Cohort Studies
  • Conjunctivitis (etiology)
  • Humans
  • Infant, Newborn
  • Ophthalmia Neonatorum (epidemiology)
  • Silver Nitrate (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: